Launch · 14 August 2026Serendipity SpaceSpace-based pharmaceutical manufacturing startup
Serendipity Space tests satellite prototype in near-space mission
By Abha Lohia · Editor ·
pre-seedBhubaneswar
- The startup tested an orbital-class satellite prototype with its Alchemy drug-crystallisation system using a stratospheric balloon at Hyderabad
- Alchemy autonomously performed drug crystallisation in harsh near-space conditions and maintained crystal integrity during recovery
- The mission validated core technologies for future orbital pharmaceutical manufacturing, including heat shields and avionics
What happened
- Serendipity Space completed a near-space mission using a stratospheric balloon at the TIFR Balloon Facility in Hyderabad.
- The mission tested an orbital-class satellite prototype that was operated and recovered successfully.
- Its Alchemy system, an autonomous drug-crystallisation platform, ran continuously in harsh near-space conditions.
- Alchemy performed drug crystallisation and maintained crystal integrity during controlled return, touchdown, and recovery.
- The payload included commercial monoclonal antibody therapeutics, small molecules, and additional proteins for drug discovery.
- The mission also tested core technologies for a future orbital fleet: advanced heat shield systems, avionics, and Alchemy.
- The team designed and built the fully functional satellite prototype in under five months and completed a month-long test campaign.
Why it matters
- The mission was inspired by Merck's development of an easier-to-inject version of cancer drug Keytruda in a microgravity lab on the International Space Station.
- CEO Antariksh Parichha observed a cancer drug being administered intravenously over six to seven hours, leading him to explore drug formulation improvements.
- India's space sector is seeing much activity, making it a good time to build such a startup.
- Many existing drugs suffer poor bioavailability due to suboptimal crystal forms; high-concentration protein formulations are unstable under gravity.
The business
- Serendipity Space aims to set up pharmaceutical laboratories in space using reusable satellites to manufacture life-saving drugs under orbital conditions.
- It plans to offer Low Earth Orbit (LEO)-based manufacturing services to pharmaceutical companies.
- Alchemy is an autonomous pharmaceutical factory for manufacturing and processing drugs in microgravity, working with small-molecule drugs and protein-based therapeutics.
- Microgravity enables superior drug crystal structures, improving solubility, stability, and effectiveness compared to Earth-based manufacturing.
- Gravity on Earth disrupts crystallisation, causing defects; microgravity could enable uniform, stable formulations.
- This could shift long IV infusions to simple at-home injections for protein-based therapies like monoclonal antibodies.
- The technology was developed at the Institute of Life Sciences incubator in Bhubaneswar, where the startup is incubated.
The founders
AP
Antariksh Parichha
co-founder and CEO- He is a physicist with a post graduate degree in Physics.
- He has worked in space tech, nuclear science, and robotics.
- His name Antariksh means 'space' in Hindi and was given by his parents.
JD
Jivitesh Debata
co-founder- He is from Odisha.
- He is an expert in robotics and AI.
DM
Dr Monica Ekal
co-founder- She is an aerospace scientist.
- She works with NASA.
What happens next
- The startup plans to undertake orbital missions next.
- It aims to scale towards conducting orbital manufacturing and returning products to Earth.
Earlier rounds
- 2025-07 · pre-seed · Undisclosed
Words to know
- microgravity
- A condition of near-weightlessness experienced in orbit, where gravity's effects are greatly reduced, allowing drug crystals to form more uniformly.
- monoclonal antibody therapeutics
- Laboratory-made proteins that mimic the immune system's ability to fight harmful pathogens, used to treat diseases like cancer.
- bioavailability
- The proportion of a drug that enters the bloodstream and is able to have an active effect on the body.
- stratospheric balloon
- A high-altitude balloon that rises to the stratosphere (about 10-50 km above Earth) to test equipment in near-space conditions.
The numbers around it
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Other articles talking about it
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 14 August 2026 →
Is this Serendipity Space? Get your “Featured on StopDown” badge →